quinoxalines has been researched along with Cavernitis, Fibrous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MJ; Han, JY; Hong, SS; Jin, HR; Kim, DK; Kim, IH; Kim, SJ; Kim, WJ; Lee, CR; Lee, SJ; Mamura, M; Park, SH; Piao, S; Ryu, JK; Shin, HY; Suh, JK; Zhang, LW | 1 |
1 other study(ies) available for quinoxalines and Cavernitis, Fibrous
| Article | Year |
|---|---|
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease.
Topics: Animals; Disease Models, Animal; Fibrosis; Humans; Imidazoles; Male; Penile Induration; Penis; Protein Kinase Inhibitors; Quinoxalines; Rats | 2009 |